The new RebiSmart® injection device offers many new updates including wireless transmission of injection times and doses MSdialog™software is designed to…
Darmstadt, Germany, 17-7-2014 — /EuropaWire/ — Merck Serono, the biopharmaceutical division of Merck, today announced the appointment of Luciano Rossetti, M.D., as…
FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by…
Merck Serono’s Grant for Growth Innovation (GGI) supports innovative projects for the advancement of science and medical research in the field of…
Investment reflects company’s ongoing commitment to innovation in fertility research Globally, seven projects receive funding from this grant cycle Darmstadt, Germany…